Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs SK Hynix (SKHY) Price & Performance

Indivior Pharmaceuticals Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Indivior Pharmaceuticals Inc. Common Stock vs SK Hynix — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B), while SK Hynix trades at $137.38 (market cap $768.83B). The key difference: SK Hynix is far larger — about 183.9× Indivior Pharmaceuticals Inc. Common Stock's market cap, and SK Hynix pays a 0.07% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and SK Hynix for 12 Days on average.

INDVSKHY
Market Cap
$4.18B$768.83B
Volume
1,819,74621,786,972
Sector
HealthTechnology
52-Week High
$41.83$198.63
52-Week Low
$24.09$126.79
Typical Hold Time
0 Days12 Days
Enterprise Value
$4.47B$718.72B
Dividend Yield
—0.07%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

SK Hynix

SKHY trades at $157.06, down 3.15% amid a sector-wide tech selloff driven by Fed rate hike concerns and competitive threats from Chinese chipmaker CXMT. The stock shows strong fundamentals with a P/E of 9.27, net income margin of 85.62%, and consistent earnings beats. Technical indicators are bearish with moving averages signaling selling pressure, though oscillators suggest potential oversold conditions. Recent news highlights AI memory demand growth but also increased competition risks.

Despite near-term volatility, SKHY maintains robust profitability and analyst consensus remains bullish with a $242 price target representing 54% upside. Key risks include Chinese competition and macroeconomic pressures, but the company's leadership in AI memory and strong financial metrics support long-term growth potential for patient investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INDV
100% Buy0% Sell
Avg holding period · 0 Days
SKHY
63% Buy37% Sell
Avg holding period · 12 Days

Top news

Latest headlines on both assets

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →

About SK Hynix

SK hynix is a South Korean semiconductor company that manufactures memory products, including DRAM and NAND flash. Its high-bandwidth memory (HBM) products are designed for high-performance computing and AI applications.

Read more on SKHY →